Podcasts about cgms

On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more... Check out all of our events like Moms' Night Out and Club 1921 here. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more.. that's coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Welcome to September! Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved – more on that coming up. But please register – the link is in the show notes. So much going on over here – tomorrow night we have our Club 1921 in Charlotte, later this month Moms' Night Out Detroit/Bloomfield and in October we're going to Seattle. Please join us. More at d-c dot com slash events. Okay.. our top story this week: XX Another indication for Mounjaro – the FDA approved it to lower the risk of major adverse cardiovascular (CV) events (MACE), including CV death, non-fatal heart attack, or non-fatal stroke in adults with type 2 diabetes who are at high risk for these events. Mounjaro – the brand name of tirzepatide - is already approved as an adjunct to diet and exercise to improve blood sugar in adults and children 10 years of age and older with type 2 diabetes. The approval was based on results from the largest and longest tirzepatide study to date, enrolling more than 13,000 participants across 30 countries over more than four and a half years. In the trial, Mounjaro demonstrated non-inferiority to Trulicity (dulaglutide), a GLP-1 treatment with established cardiovascular benefit, with an 8% lower rate of cardiovascular death, heart attack or stroke (MACE-3). The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI: 0.83, 1.01) for Mounjaro compared to Trulicity (dulaglutide). https://www.prnewswire.com/news-releases/fda-approves-lillys-mounjaro-tirzepatide-to-reduce-cardiovascular-risk-in-adults-with-type-2-diabetes-302862415.html XX The FDA approves the Libre Duo – the first device designed to continuously monitor both blood sugar levels and ketone levels in people with diabetes. The Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System is now approved for those ages 2 and older. Until now, the agency said, people had to monitor ketone levels with separate tests that only provided a single measurement at one point in time. The new system combines blood sugar and ketone tests and monitors them continuously. Readings -- and alerts in case of dangerous trends -- are sent wirelessly to a smartphone app. The FDA previously granted "breakthrough device" status to the system, which is meant to expedite the device's development and review. https://www.upi.com/Top_News/US/2026/08/25/fda-oks-blood-sugar-ketone-monitor/5521787688375/ XX Diabetes tech firms Dexcom and Abbott are watching closely for a Medicare coverage expansion that could significantly broaden access to their glucose sensors. The Centers for Medicare and Medicaid Services is expected to expand Medicare coverage of continuous glucose monitors to people with diabetes who do not take insulin. Currently, coverage is limited to people with Type 1 or Type 2 diabetes who take insulin or have a history of problematic low blood sugar. Dexcom CEO Jake Leach told investors in a late July earnings call that the company expects to hear back from the CMS before the end of the year, with coverage going into effect in mid-2027.     Dexcom presented results of a randomized, controlled trial earlier this summer at the American Diabetes Association's Scientific Sessions that it expects will support the CMS' decision. The 26-week study found that people who used a CGM had a larger hemoglobin A1C reduction than the control group and spent five more hours per day in a normal glucose range than the control group. https://www.medtechdive.com/news/dexcom-abbott-await-medicare-coverage-expansion-for-cgms/828775/ XX A new study suggests continuous glucose monitors (CGMs) may offer benefits for people with type 1 diabetes that go beyond improving blood sugar and reducing hypoglycemia.   Researchers analyzed health records from more than 8,400 adults with type 1 diabetes receiving care through the Veterans Health Administration. Over one to four years of follow-up, people who started using a CGM had a 10% to 16% lower risk of death from any cause compared with those who did not use one.   The association appeared strongest among people over age 65 and those who were not using insulin pumps. Researchers did not find meaningful differences based on A1C, race or ethnicity, or frailty.   Importantly, this was an observational study using medical records, not a randomized clinical trial, so it cannot prove that CGM use directly caused the lower death rate. But the findings suggest CGM may have important long-term health benefits beyond glucose management.https://visualize.jove.com/42319755-continuous-glucose-monitoring-initiation-is-associated-with-reduced-mortality-in-older-onset-type-1-diabetes-patients-a-target-trial-emulation-study-within-the-veterans-health-administration XX We've been talking about people without diabetes using CGMs for a long time.. now a new study weighs in. Research published in JAMA finds that this wellness trend isn't helpful for people without a diabetes diagnosis. They found that the strongest evidence for CGM use is for people who are already living with diabetes, but not for those without the condition who use them for wellness purposes. It's also worth noting, though, that this new study is a narrative review. This means that the researchers drew their conclusions from the findings reported in several other studies. More randomized controlled trials would be necessary to see whether there are any meaningful health benefits of using a CGM if you don't have diabetes.   Dower also warned that constantly monitoring your blood sugar when you don't have diabetes could lead to unintended health anxiety. In some cases, you may even make accidental lifestyle changes that could be harmful. "[Blood sugar] spikes may occur after meals, but if this leads someone to replace healthy food such as fruit with unhealthy food such as something high in fat but low in carbohydrate, the glucose information has done more harm than good," Dower said. https://www.verywellhealth.com/blood-sugar-monitor-for-people-without-diabetes-12058575   XX   Could metformin somehow influence the biological processes that drive aging? A new review found evidence that metformin may affect several key features of aging, including how cells use energy, inflammation, cellular damage and even some changes in gene activity. Animal studies have shown longer lifespans or improvements in markers of biological aging, while some human studies have also found promising results.   But researchers say there's still no proof that metformin actually slows aging or helps healthy people live longer. Most human research has involved people with diabetes or other health conditions, and one large trial found that while metformin helped prevent type 2 diabetes, it did not reduce cancer, cardiovascular disease or deaths.   Researchers say larger clinical trials in people without diabetes are needed to determine whether metformin can truly extend healthy lifespan—or whether its benefits are primarily related to preventing and treating specific diseases. https://www.technologynetworks.com/drug-discovery/news/metformin-may-influence-longevity-through-the-gut-microbiome-and-epigenetic-changes-416035 XX More to come including more research on a spice thought to help diabetes, predictions about the number of people who may be living with type 1 in the years to come around the world, and a connection I didn't know about between diabetes and Dolly Parton.   XX A compound found in turmeric may help protect blood vessels from some of the damage caused by Type 1 diabetes. In rats, curcumin reduced inflammation, improved cellular signaling, and restored vascular health to levels resembling those of nondiabetic animals. The results hint at a possible new way to reduce the long-term cardiovascular risks of diabetes, but human trials are still needed. Curcumin, the natural compound responsible for turmeric's vivid yellow color, is widely studied for its anti-inflammatory and antioxidant properties. https://www.sciencedaily.com/releases/2026/08/260824065543.htm XX New research estimates the number of people living with type 1 diabetes (T1D) worldwide will increase by 29% from 9.4 million in 2025 to 12.1 million in 2049. This will be presented at EASD, the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2 The USA will see an increase of over half a million, going from 1,492,825 to 2,055,235. The authors suggest that the reasons for the predicted high incidence and prevalence in 2049 in countries such as Australia, US, UK are likely to be a combination of genetics, environmental triggers and also high case detection rates (due to the good health care infrastructure here and in other HIC). Unlike previous estimates, the DIAMOND-T1D model takes historical patterns of insulin availability into account and aims to provide global, regional and country-specific estimates of T1D incidence, prevalence and mortality from 1900 to 2050. Although the majority of people with T1D live in high-income countries (HIC) and middle-income countries (MIC), the largest relative increase in the T1D prevalence is expected to occur in LIC as access to insulin, glucose monitoring and survival all improve in those countries. https://www.news-medical.net/news/20260828/Type-1-diabetes-cases-projected-to-increase-worldwide-by-2049.aspx XX Early initiation of statins after a diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study published in The Lancet Regional Health – Europe. According to the Lancet Commission, nearly half of dementia cases could theoretically be prevented by eliminating 14 risk factors. "Detecting and treating high levels of low-density lipoprotein cholesterol (LDL-C) from midlife is one such highlighted risk factor," From Danish registers, researchers identified 132,585 statin-naive individuals who developed type 2 diabetes from 2006 through 2019, with follow-up until the end of 2021.   Medical records were searched for diagnoses of all-cause dementia. A clone-censor-weight design was used to analyze dementia incidence in patients with no statin initiation within five years after diagnosis, in those with early statin initiation within one year and in those with late statin initiation between one and five years after diagnosis.   https://medicalxpress.com/news/2026-08-early-statins-diagnosis-diabetes-dementia.html   XX We are heartbroken over the loss of our friend Dolly Parton. Dolly was a beloved icon whose extraordinary generosity, warmth, and compassion touched countless lives, including those of the Children's Diabetes Foundation and the Barbara Davis Center for Diabetes. Her support of The Carousel Ball and Carousel of Hope Ball reflected her deep commitment to helping children and families affected by type 1 diabetes. Beyond her remarkable talent, Dolly will be remembered for the kindness and joy she shared so generously with others. Our hearts are with her family, friends, and all who loved her as we celebrate her extraordinary life and lasting legacy. She will be deeply missed.    

Dr. Mohammad Ashori is a board-certified family medicine physician, health coach, and rock climber. We talked about the importance of putting on muscle, how much rest we need between training sessions, nutrition and metabolic health, zone 2 cardio, key metrics and blood markers to track, different levels of data, why some data can be misleading or harmful, relative vs. absolute risk, and much more. Want to work with Dr. Ashori? Get 15% off your 1st health assessment with Dr. Ashori. Book your schedule here and use the code: NUGGET15 Want climbing or nutrition coaching? Free Masterclass (Learn more about Climb Accelerator)

Episode 2846 - Vinnie Tortorich and Dr. Gary Fettke discuss CGMs, dietary guidelines, GLP-1s, and the third rail of how the COVID-19 pandemic was handled. https://vinnietortorich.com/2026/08/the-third-rail-dr-gary-fettke-episode-2846 PLEASE SUPPORT OUR SPONSORS Pure Vitamin Club Pure Coffee Club NSNG® Foods VILLA CAPPELLI EAT HAPPY KITCHEN YOU CAN WATCH THIS EPISODE ON YOUTUBE - @FitnessConfidential Podcast Vinnie's workout videos are available to purchase! Choose from a 2-day, 4-day, or 6-day workout–or buy all three at a discount! TO PURCHASE VINNIE'S WORKOUT VIDEOS, CLICK THIS LINK: https://vinnietortorich.com/workout Guidelines and GLP-1s Dr. Gary Fettke was in Vinnie's first documentary, "FAT: a documentary." They discuss how dietary messaging has changed over the years. (8:00) Whole foods, including animal proteins, are the optimal way to get nutrients. (15:00) They discuss CGMs and how helpful they can be for awareness of what certain foods do to your blood glucose. (20:30) Your body responds to everything you eat; however, some foods raise glucose levels more than others. A CGM can help you discover your personal response and bioindividuality. They discuss the U.S. Food Pyramid and RFK's take on it. Following the previous dietary guidelines has not helped; in fact, it seems to have made things worse. For example, approximately 40% of the U.S. military members are overweight because of food served in military commissaries. (32:00) The Magic Pill documentary is fantastic viewing. (33:00) Vinnie asks Gary his opinion on GLP-1s. (41:00) The mechanisms in the body when using a GLP-1 are very similar to being on a low-carb, ketogenic diet. (44:00) Significant weight loss requires keeping protein levels up to help offset muscle loss. (48:00) Exercise is very important, and can help with loose skin. The Third Rail They discuss Gary's experience during the COVID pandemic, or "the third rail." (57:30) He also shares thoughts about the recent hearings where Anthony Fauci and he "pleaded the Fifth" 111 times. The result of the pandemic is a percentage of the population realizing not to mindlessly follow medical authorities, which is good. Stay inquisitive and question what comes across the news and social media. Alcohol dampens T-cell lymphocytes' function; ketones will boost them. (1:17:00) Belinda Fettke's Substack can be found at https://truthzones.substack.com You can find Dr. Gary Fettke on X @FructoseNo. You can also search for him on YouTube. Check out the Aletha Hip HookTM that Vinnie uses to reduce pain and increase mobility: You can purchase your own through Vinnie's website here: https://vinnietortorich.com/hook Anna's products are now linked to PureVitamin Club's website. Look under the "Food and Snacks" section to purchase them there, too. https://purevitaminclub.com/collections/food-and-snacks Vinnie hopes to add other products as well, all of which will be health-related. The NSNG® VIP GROUP IS NOW CLOSED AGAIN AS OF SUNDAY, MARCH 15TH Anna's next cookbook, Eat Happy Cocktail Hour, is filled with cocktails, mocktails, and appetizers and is available for pre-order right now. If you pre-order, you'll get bonus goodies! You can pre-order from a wide variety of booksellers at https://eathappycocktailhour.com/ Please save your receipt from wherever you pre-order; you'll need it for your bonuses! Physical Release Date is October 2026 You can book a consultation with Vinnie to get guidance on your goals. https://vinnietortorich.com/phone-consultation-2/ More News Serena has added some of her clothing suggestions and beauty product suggestions to Vinnie's Amazon Recommended Products link. Self Care, Beauty, and Grooming Products that Actually Work! https://www.amazon.com/shop/vinnietortorich/list/3GPVU29UHHPMY?ref_=aipsflist Don't forget to check out Serena Scott Thomas on Days of Our Lives on Peacock. "Dirty Keto" is available on Amazon! You can purchase or rent it here.https://amzn.to/4d9agj1 Please watch, rate, and review it! Eat Happy Italian, Anna's second cookbook, is available! You can go to https://eathappyitalian.com You can order it from Vinnie's Book Club. https://amzn.to/3ucIXm Anna's recipes are in her cookbooks, on her website, and on Substack —they will spice up your day! https://annavocino.substack.com/ PURCHASE DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views it receives, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries

GLP-1 receptor agonists have transformed weight loss and metabolic health—but what are we overlooking? In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald is joined by Dr. Sanjay Bhojraj and Dr. Alexis Gonzales to explore the clinical tradeoffs of GLP-1 therapy, including lean muscle preservation, nutrient status, weight regain, and long-term metabolic health. The conversation also examines SiPore, an engineered silica-based intervention that works locally in the GI tract to slow the breakdown and absorption of carbohydrates and fats. Dr. Fitzgerald and her guests discuss findings from the randomized, double-blind, placebo-controlled SHINE trial, including outcomes related to A1c, visceral fat, waist circumference, cholesterol, and lean mass. They also explore how CGMs can reveal post-meal glucose patterns, why muscle preservation matters during weight loss, and how clinicians can support patients transitioning off GLP-1 medications—including those preparing for pregnancy, IVF, or surgery. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Sanjay Bhojraj, MD, FACC is an interventional cardiologist and Fellow of the American Academy of Anti-Aging Medicine specializing in cardiometabolic health, longevity medicine, and precision cardiovascular prevention. He's the founder of the Laguna Institute of Functional Medicine. His programs focus on reversing metabolic dysfunction, improving resilience, and reducing cardiovascular risk through lifestyle optimization and advanced diagnostic testing. Dr. Alexis Gonzales ("Dr. G") is OvationLab's Senior Clinical Implementation and AI Specialist, translating breakthrough research into practical clinical workflows, and holds advanced degrees in biochemistry (Saint Mary's), biotechnology (Johns Hopkins), and naturopathic medicine (Bastyr). She provides concierge functional-medicine care at her private practice in California—focusing on endometriosis, fertility, PCOS, and menopause—while distilling emerging research into practical frameworks at conferences to make integrative solutions accessible. http://sigridpro.com/DRKF THANK YOU TO OUR SPONSOR SIGRID http://sigridpro.com/DRKF *CONNECT with DrKF* Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: https://www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

What if seeing your blood sugar change in real time could make healthy habits easier to understand and sustain? This week on Health Coach Talk, Dr. Sandi welcomes Functional Medicine Coaching Academy graduates Michelle Doel and Alicia Harding, co-founders of the Metabolism Mastery Method, to explore how continuous glucose monitors, or CGMs, can support greater awareness of metabolic health and meaningful behavior change.Full show notes: https://functionalmedicinecoaching.org/podcast/michelle-doel-alicia-harding-193/

Send us Fan MailBlood sugar is everywhere right now. Glucose spikes, continuous glucose monitors, apple cider vinegar before meals, walking after meals, berberine, cutting carbs… but how much of this actually matters?In this episode, we're joined by Dr. Adrian Chavez, who has a PhD focused on insulin resistance and metabolic health, to break down what you actually need to know about blood sugar.We talk about what insulin resistance really is, why it can develop years before diabetes, whether fasting insulin and HOMA-IR are worth testing, what a normal blood sugar response after eating should look like, and whether healthy people actually need to worry about glucose spikes.We also get into CGMs, berberine, apple cider vinegar, post-meal walks, calorie intake, body fat, strength training, cardio, fibre, protein, and the lifestyle changes that actually make the biggest difference for metabolic health.Plus, we zoom out into a much bigger conversation about the wellness industry, health optimization, and why so many people are spending enormous amounts of time and money worrying about tiny details while overlooking the habits that have the strongest evidence behind them.If you've ever wondered whether you're insulin resistant, what blood work actually matters, or what you should be doing to protect your metabolic health long term, this episode will give you a much clearer place to start.In this episode, we discuss:• What insulin resistance actually is• How insulin resistance can develop before diabetes• Fasting insulin and HOMA-IR• Whether blood sugar spikes are actually harmful• Continuous glucose monitors for healthy people• Berberine and whether it actually works• Apple cider vinegar and post-meal walks• Strength training, cardio and daily movement• Calorie intake, body fat and metabolic health• Protein, fibre and blood sugar control• The problem with over-optimizing your health• What actually matters for long-term wellnessFollow Dr. Adrian Chavez on Instagram: @dr.adrianchavezListen to The Nutrition Science Podcast wherever you get your podcasts.Use code GGW20 for 20% Stay Above Nutrition products (US & Canada)!You can check them out hereSHOP OUR MERCH HERE

Are prevention-focused labs and early screening actually catching disease before conventional medicine would, and is anyone doing enough of it? In this episode, Amber Warren, PA-C is joined by Michael Orloff, PA-C, a board-certified physician assistant who spent over a decade in emergency and trauma medicine before transitioning to functional medicine, to explore how cardiometabolic testing, early cancer screening, and lifestyle-first care can help patients stay out of the healthcare system altogether. Mike shares what he's seeing after his first year at FMI, coming from years of treating end-stage disease in the ER, and breaks down why he focuses on ApoB and lipoprotein(a) instead of relying on standard cholesterol panels alone, how zone-based training and lactate threshold testing let him build truly individualized cardiovascular prescriptions, and why insulin sensitivity sits at the center of long-term metabolic health. He also discusses why cancer screening guidelines often lag behind what he sees clinically, why radon exposure is an overlooked cancer risk in the Treasure Valley, and how simple, low-effort movement, like walking after meals, can meaningfully shift blood sugar and body composition. Whether you're trying to make sense of your cholesterol labs, curious about CGMs, thinking about weight loss, or just want a clearer picture of what proactive, data-driven prevention actually looks like, this episode offers practical insight from someone treating these issues every day. In this episode, you'll learn: How ApoB and lipoprotein(a) provide a more complete cardiovascular risk picture than LDL alone How zone two training, lactate threshold, and VO2 max testing personalize exercise prescriptions Why insulin sensitivity is central to cardiometabolic and metabolic health Practical levers for sustainable weight loss: dietary restriction, meal timing, and portion control How a continuous glucose monitor (CGM) reveals real-time, individualized blood sugar patterns Why early cancer screening, including colonoscopies, PSA, and CA-125, may need to start earlier than conventional guidelines suggest How environmental factors like radon exposure raise cancer risk in the Treasure Valley Why time, not motivation, is often the biggest barrier to aging well, and how to work around it Stay tuned for more conversations on functional medicine, cardiometabolic health, cancer prevention, longevity, and optimizing your health from the inside out!

On this episode of Diabetes Connections In the news… Sanofi acknowledges an insulin shortage, a new oral therapy for type 1 moves along in research, could there be an actual, accurate, non-invasive CGM in the works, ADA conflict continues and a new documentary about Girl Scout cookies shines a spotlight on T1D. Don't miss our upcoming events! Moms' Night Out in Detroit and Seattle, Club 1921 in Charlotte and Phoenix: https://diabetes-connections.com/events/   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com   Transcript:  (Stacey Track) On this episode of Diabetes Connections In the news… Sanofi acknowledges an insulin shortage, a new oral therapy for type 1 moves along in research, could there be an actual, accurate, non-invasive CGM in the works, ADA conflict continues and I can't wait to tell you about Cookie Queens.. that's coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. We are still looking for your community commercials. These are 30–60 second audio spots created by members of the diabetes community to share: Events you're organizing: a fundraiser, walk, or local meetup Products you've created: maybe you've written a book, have a Substack, designed a T1D-friendly gadget, or launched a small business Helpful projects or resources: things you think others in our community should know about It's your chance to share what you're doing and help others get connected! Full instructions are on the website. While you're there please check out our events. We're turning toward fall and we have a lot going on – MNO and Club 1921.   Okay.. our top story this week: XX I want to talk about Cookie Queens! It might not sound like a hard news story.. but It's my show and I can't wait to watch this. This move follows four Girl Scouts ages 5-12 during cookie season. One of the girls has type 1 – they don't mention it in the trailer, but you can see her omnipod. Here's a clip:   Start the very beginning and stop after "I want to be a supreme court justice." (stop after the "oh..laughter" https://www.youtube.com/watch?v=nnSQS43Eil8   Viewers meet Ara from San Diego, CA (5), Shannon Elizabeth from El Paso, TX (8), Nikki from Chino, CA (9), and Olive from Charlotte, NC (12). Ara has Type 1 diabetes and is shown taking insulin, refilling her pump before bed, and determining with her dad how to sample the cookies she's selling while keeping her blood sugar levels safe. Thumbs down to the Hollywood reporter dot com. In their review they say.. "if this film were itself a baked good, Ara would need to be careful because one bite could cause hyperglycemia or even diabetic ketoacidosis. It's just that sweet." Cookie Queens comes out this month. https://www.hollywoodreporter.com/movies/movie-reviews/cookie-queens-review-prince-harry-meghan-markle-girl-scouts-1236484555/ trailer:   XX Supply issues for Lantus SoloStar pens being acknowledged by Sanofi. The company says it's experiencing "a period of intermittent supply due to increased demand. The company said the increase in demand is being driven by "broader market dynamics," but did not provide additional details. Sanofi said the situation is temporary and is expected to improve over the coming weeks. The company said Lantus U-100 vials and Toujeo U-300, which contain the same active ingredient, remain available. https://www.wral.com/news/local/common-insulin-pen-faces-supply-issues-amid-rising-demand-july-23-2026/ XX The University of Alabama at Birmingham startup TIXiMED Inc. has launched the next phase of clinical testing for a novel oral therapy for Type 1. For now called TIX100, a small-molecule drug designed to inhibit a protein linked to pancreatic beta-cell loss and diabetes progression. The new double-blind, randomized, placebo-controlled study will evaluate the drug's safety, tolerability and pharmacokinetics. Researchers will enroll 18 healthy participants across three dose cohorts at a single United States study site. Participants will receive either TIX100 or a placebo twice daily for 28 days, followed by a seven-day follow-up period. Six participants making up the first cohort have been successfully enrolled thus far. In addition to its potential use in Type 1 diabetes, TIX100 may have applications in Type 2 diabetes and obesity. A recent study found that the drug prevented weight regain and preserved lean muscle mass after discontinuation of GLP-1 therapies in preclinical models. https://www.uab.edu/news/research-innovation/startup-advances-novel-oral-type-1-diabetes-therapy-to-next-phase-of-human-testing XX Researchers at the University of California San Diego say they have developed and validated a Continuous Health Analyzing Ring Module (CHARM), a compact, fully integrated wearable smart ring capable of continuous real-time monitoring of multiple biomarkers in sweat. The wearable device can simultaneously measure up to four biomarkers, including glucose, ketone, uric acid, lactate, ascorbic acid, and alcohol, to provide real-time insights into metabolic health. The study is published in Nature Communications. They say CHARM device contains all necessary biomarker sensors, low-power electronics, and a flexible battery. The left compartment of the device is designed to draw sweat passively using an osmotic hydrogel, a soft polymer that creates a pressure gradient to pull fluid from the skin painlessly. The sweat is then analyzed by multiplexed electrochemical sensor arrays within the same compartment, leading to simultaneous and real-time tracking of four biomarkers at a time.   The right compartment of the device contains a flexible zinc-silver oxide rechargeable battery that supplies power for up to 12 hours of operation between charges. Biomarker information generated through sensors is wirelessly transferred to a connected Bluetooth-enabled device for real-time display The findings indicated that the device performed well in initial temperature, cytotoxicity, and on-body compatibility tests. It also demonstrated high analytical accuracy in preliminary studies involving healthy participants and individuals with type 1 diabetes, highlighting its potential for non-invasive metabolic monitoring. The calculated estimated sweat-based blood glucose concentration showed a mean absolute relative difference of approximately 13.7% against its corresponding blood concentration values.   The device needs further validation in diverse clinical settings and across large diabetic cohorts.   https://www.news-medical.net/news/20260727/Prototype-smart-ring-tracks-multiple-sweat-biomarkers.aspx   XX Hotter weather and rising temps appear to increase the short term risk for low blood sugar in adults with type 1. An analysis of more than 32 million continuous glucose monitor (CGM) readings from nearly 700 adults with T1D in the UK showed a 26% greater risk for hypoglycemia at a temperature of 25 °C (77 °F) than at 13 °C (55.4 °F). Hypoglycemia was defined as a glucose level < 3.9 mmol/L (70 mg/dL). The study included 679 individuals with T1D and 32,966,282 CGM readings collected between February 23, 2017, and August 8, 2024. Participants had a mean age of 46.4 years and a mean T1D duration of 23.7 years. The researchers observed strong seasonal patterns, with lower odds of hypoglycemia in late winter and early spring, followed by a peak during the summer. The lowest risk occurred on Mondays. The odds then increased over the course of the week and peaked toward the weekend, with a significant odds ratio of 1.14 on Saturdays compared with Mondays. Increases in hypoglycemia were observed during both hot and cold weather, but the association was stronger for heat. The net odds ratio was 1.26 at 25 °C compared with 13 °C.   https://www.medscape.com/viewarticle/when-temperatures-climb-hypoglycemia-risk-rises-type-1-2026a1000q4r XX Seven weeks after the expulsion of five diabetes experts from the American Diabetes Association conference, controversy continues. More than 200 members now calling for two ADA leaders to resign. In response, the ADA delivered its own message Tuesday, expressing appreciation for members' patience while a report is prepared.   The resignation demand, sent last week in an open letter to the ADA board of directors, calls for the removal of CEO Charles Henderson and chief scientific and medical officer Rita Kalyani. It also urges "an independent investigation into the events of the 2026 Scientific Sessions in New Orleans, a full apology to the five colleagues removed from the meeting, and the restoration of editorial independence at Diabetes Care," an ADA scientific journal.   https://www.statnews.com/2026/07/28/american-diabetes-association-fallout-researchers-expulsion/ XX XX Still to come, , a new link between diabetes and dementia, device updates, and why you might want to start rooting for the Red Sox..   XX New study says that people diagnosed with type 1 diabetes (T1D) before the age of 10 years had a 37% higher risk of developing all-cause dementia later in life than those diagnosed between ages of 18 and 30 years. These researchers used a Swedish national register of 43,440 individuals with T1D (mean age at cohort entry, 33 years; 44% women) Worth noting a couple of things.. the mean age in this study was 33 – so the people who were diagnosed under the age of ten would not have had access to current technology – no CGMs or AID systems. And while the study says it's 37% higher for the younger group, the actual rate was still very low. As always, I'll link to the study so you can learn more. My obvious bias here to look for a silver lining because I have a son who diagnosed with T1D at age 2.   https://www.medscape.com/viewarticle/type-1-diabetes-onset-before-age-10-tied-higher-risk-2026a1000pir XX Researchers have developed a machine learning model that uses routine clinical information to detect diabetes and distinguish between type 1, type 2, prediabetes, and diabetes caused by pancreatic disease. The model performed well in early testing, but researchers say it still needs to be validated in independent patient groups before it could be considered for use in diabetes screening or clinical care. It did not assess clinical utility, patient outcomes, or quality of life. https://www.news-medical.net/news/20260729/Researchers-train-AI-to-detect-diabetes-and-assign-four-diagnostic-labels.aspx XX Trinity Biotech and Latch Medical are teaming up to explore combining CGM with precision drug delivery technology for diabetes, obesity, and other metabolic conditions. The companies hope real-time glucose data from Trinity's CGM+ sensor could eventually help guide more personalized treatment decisions and medication delivery. Trinity's CGM+ is still in development, with a pivotal clinical trial planned for later this year. https://www.drugdeliverybusiness.com/trinity-biotech-collab-cgm-drug-delivery/ XX The FDA selects Dexcom as the first participant in a new digital health pilot that will exempt certain digital health devices from FDA premarket authorization requirements while collecting real world data through a complementary Medicare program. Dexcom, plans to implement an artificial intelligence-enabled glucose health program through the pilot. The program is intended to help screen for prediabetes and Type 2 diabetes. The company plans to integrate data from its sensors, including its prescription G7 CGM and its over-the-counter Stelo device, along with contextual health information such as nutrition, physical activity, sleep and stress. The FDA announced plans for the Technology-Enabled Meaningful Patient Outcomes, or TEMPO, pilot last year amid a broader push for adoption of digital health and wearables. It coincides with a new program by the CMS to fund the use of digital technologies for managing chronic conditions. https://www.healthcaredive.com/news/fda-names-dexcom-as-first-participant-in-digital-health-pilot/826215/ XX Medicare and Medicare Advantage beneficiaries now have access to the new MiniMed Flex insulin pump. Beneficiaries can now access the MiniMed Flex and its latest sensor portfolio, which currently includes the Simplera Sync sensor, a disposable, all-in-one sensor with easy two-step insertion. The company plans to roll it out with the Instinct sensor, made by Abbott, later this summer. It also added Abbott's dual glucose-ketone sensor (still investigational in the U.S.) to its portfolio this year. Flex picked up FDA clearance in March and the company announced the initial commercial rollout of the pump last month. https://www.drugdeliverybusiness.com/minimed-flex-pump-now-available-medicare/ XX Eli Lilly expands it's partnership with Resilience – the makers of the KwikPen device. Through the investment, Resilience will significantly increase U.S. production of Lilly's KwikPen injectable device for diabetes and obesity medicines. In February, Lilly won FDA approval for Zepbound in a multidose KwikPen device. The product includes four doses of the GLP-1/GIP receptor agonist, providing a month of treatment for obesity or overweight in one device. Resilience expects the KwikPen capacity expansion to create at least 400 jobs in the Cincinnati area. https://www.biospace.com/deals/lilly-and-resilience-invest-750m-in-diabetes-and-obesity-drug-device-supply XX Alex Cooper – the host of the top podcast Call her Daddy – announced she's been diagnosed with gestational diabetes.   "When I got this diagnosis, the first couple days, I was really hard on myself," the 31-year-old admitted. "It felt very isolating, like, as much as my family and my husband and everyone was there for me I just felt like, it's me on an island." She says she found an online community that's been helping. In sharing her experience, she hoped it would alleviate the stress. https://www.eonline.com/news/1434556/pregnant-alex-cooper-shares-isolating-gestational-diabetes-diagnosis XX Several amazing diabetes non profits are vying for big charity dollars from the Boston Red Sox. The IMPACT Awards provide Red Sox fans with the chance to nominate their favorite, most impactful nonprofit organization serving New England for their opportunity to win a grant from the Red Sox Foundation. In 2026, the IMPACT Awards will focus on organizations that are supporting research and providing awareness, advocacy, and services to people with diabetes. Check out all the charities and vote for your favorites – you've heard of so many of these I promise – at the link in the episode show notes, . https://www.mlb.com/redsox/community/red-sox-foundation/impact-awards?partnerId=redirect-bos-impact

Blood sugar is the master dial. If your energy crashes at 3pm, if the cravings run you, if the belly weight will not move no matter how clean you eat, this is not a willpower problem. It is a blood sugar problem, and it is fixable. In this episode I break down blood sugar for women from the ground up: what glucose and insulin actually do, the six levers that throw them off, the full diabetes spectrum from prediabetes through Types 1 to 4 (including the lean, skinny fat Type 4 that surprised me), and the exact labs and CGMs to run. Then I give you my full stack across four pillars: nutrition, lifestyle, supplements, and peptides. I also get into how the GLP-1s and the growth hormone peptides move your blood sugar in opposite directions, PMOS (the newly renamed condition you have known as PCOS) where insulin is the real root, and how to actually get a CGM here in Canada now that the US apps like Levels do not ship north of the border. If you want me to build this protocol with you, you can book a free call here.   Timestamps: 04:15 - What blood sugar is: glucose and insulin 07:38 - Lever 1: spikes, crashes, and cravings 11:31 - Lever 2: insulin, belly fat, and fat storage 15:45 - Lever 3: insulin resistance and HOMA-IR 19:17 - Lever 4: glycation and your HbA1c 24:04 - Lever 5: cortisol, how stress spikes sugar 26:29 - Lever 6: your hormones, cycle, and perimenopause 34:16 - The diabetes spectrum: prediabetes and Types 1 to 4 46:17 - Symptoms: how to tell your blood sugar is off 48:03 - Labs and CGMs, and how to get one in Canada 57:06 - Pillar 1: nutrition to flatten the spike 1:13:55 - Pillar 2: lifestyle, walking, muscle, sleep 1:18:45 - Pillar 3: supplements (magnesium, inositol, berberine) 1:25:43 - Pillar 4: peptides, GLP-1s, and PMOS Resources: Work with me one-on-one. The Her Stack Planner (digital or prints at home). My trusted Peptide Source Guide. Join The LongHer Life Longevity Community. Products mentioned: Run your labs with SiPhox Health (code BRITTANY20). Function Health full-body labs (US). NiaHealth labs (Canada). Baja Gold minerals and electrolytes. Code BIOHACKINGBRITTANY. Ovii Metabolic Sync. Code BIOHACKINGBRITTANY. Let's connect: Instagram, TikTok, Facebook Shop my favorite health products. Listen on Spotify, Apple Podcasts, YouTube Music. This is for educational purposes only. This is not medical advice.

Dave Crosland and Scott McNally break down the real differences between Anadrol and Winstrol during a contest cut before answering rapid-fire questions on TRT, Tren, HGH, SHBG, estrogen management, Nandrolone for joint pain, cycle design, bloodwork, CGMs for bodybuilding, and much more. 0:00 Anadrol vs Winstrol (Preview) 0:25 Support Our Sponsors 5:00 Anadrol vs Winstrol in a Contest Cut 8:30 Steroid Cycles Around a Rotation Job 13:50 Can P5P Reduce Tren Side Effects? 15:25 What Causes High SHBG? 19:40 CGMs for Bodybuilding: Worth It? 23:30 DIM & Calcium-D-Glucarate for Estrogen 25:45 When TRT Changes Your Life 27:35 Is a 50-Pound Second Cycle Realistic? 32:30 Painful Pharma Testosterone Injections 33:30 Should You Bulk with Tren? 35:00 Kenalog, Allergies & Muscle Growth 37:10 Managing Low Estrogen on Cycle 38:00 Nandrolone for Joint Pain 40:29 ApoB vs HDL: Which Matters More? 43:15 HGH Raw Supply Update 48:00 Switching from NPP to Tren 49:30 Is TRT Microdosing Dying? 51:20 Keeping Testosterone High Off TRT 54:00 When to Kickstart a Cycle 59:25 Bloodwork Options in Canada 1:02:00 Uncle Dave's Wisdom UK Blood Work Get your Labs done by Dave in the UK : https://evalbloodanalysis.com/home/ Support the Podcast Patreon — Help keep the show growing. Even $5/month makes a difference. https://www.patreon.com/thinkbigbodybuilding Sponsors TRUE NUTRITION — Custom supplements for serious lifters Use code THINK to save https://www.truenutrition.com/THINK STROM SPORTS — Performance supplements trusted by athletes UK: https://tinyurl.com/ydmbfa54 US: https://stromsportsus.com Supplement Source Canada — Top brand supplements with fast shipping http://www.supplementsource.ca Merch Official THINK BIG Merch — Train, represent, support the brand https://think-big.printify.me/products

Integrative oncologist Dr. Nina Fuller-Shavel joins me to explain why cancer rates are climbing in midlife women, even those who look healthy on paper. WHAT YOU'LL LEARN -       Why cancer rates are rising even in midlife women who look and feel healthy -       The gut-estrogen connection: how your microbiome affects hormone-driven cancer risk -       The 3 simple interventions that cut cancer risk by 60% in a landmark trial -       How strength training lowers inflammation and disease risk -       Why lifetime estrogen exposure matters more than the estrogen drop in perimenopause -       Why standard HRT dosing gets it wrong, and what blood levels to actually ask for -       Why TSH alone can't tell the full thyroid story, and what a full panel should include -       How chronic stress and trauma quietly drive long-term disease risk TIMESTAMPS 00:00 Why Cancer Rates Are Rising in Midlife Women 09:44 The Vitamin D, Omega-3 and Strength Training Protocol That Cut Cancer Risk by 60% 18:17 Perimenopause, Estrogen Exposure and Why HRT Dosing Alone Isn't the Answer to Cancer Risk 28:10 Hashimoto's, Thyroid Antibodies and Why TSH Alone Is Misleading You in Perimenopause 36:02 Inflammation, Cortisol and Chronic Stress: The Hidden Drivers of Disease Risk in Midlife 43:57 Trauma, Boundaries and Why Saying No Is a Non-Negotiable in Midlife Health 51:35 Full Body MRIs, Genetic Testing and Polygenic Risk Scores: What's Actually Worth Doing 59:03 Wearables, CGMs and the One Longevity Message Every High-Achieving Woman Needs to Hear .  VALUABLE RESOURCES ●      Synthesis Clinic (Dr. Nina's integrative oncology practice)

Immune Regulation, Omega-3 Nuance, and Himalayan Tartary Buckwheat with Dr. Austin Perlmutter, chief science officer of Big Bold Health. He details immune regulation as a nuanced, multidimensional system shaped by diet and lifestyle rather than simple “boosting.” Perlmutter explains Big Bold Health's focus on immunometabolism, educating about immune complexity, and conducting studies on nutraceuticals, including use of CGMs and clinical trials. He discusses why eating fish often outperforms refined fish-oil supplements, noting conventional processing (heat, bleaching, deodorizing, esterification) and loss of other lipids and nutrients. Perlmutter highlights specialized pro-resolving mediators (resolvins, protectins, maresins) and vitamins A and D as potentially better preserved in minimally processed oils, and reviews typical omega-3 intake and target ranges. The conversation also covers immunosenescence/inflammaging and Big Bold Health research on sprouted Himalayan Tartary Buckwheat, its high polyphenols (rutin, quercetin), microbiome effects, and studies including epigenetic aging clocks and brain outcomes.

Melissa Slemp has lived with type 1 diabetes for 44 years — since she was diagnosed in 1982, before glucometers, before CGMs, back when insulin came from vials and syringes and "boiling your needles" was still a recent memory for a lot of people. In this episode, we trace that whole arc: what early management actually looked like, the high-risk pregnancy she navigated in the 90s, and the moment — after more than four decades on injections — she finally switched to a pump. If you've ever wondered what it's like to hand over that much control after that much time, this is the conversation. But the real heart of this episode is what happens to blood sugar when a woman with type 1 diabetes hits perimenopause. Melissa walks through her own experience of watching her basal insulin needs climb for no obvious reason, the years she spent without an explanation, and what she eventually learned about estrogen, progesterone, and insulin resistance — knowledge she says she had to dig up herself, because most endocrinologists and OBGYNs simply aren't trained in the overlap. That research became the reason she wrote Highs, Lows, and Hormones, a survival guide for women navigating diabetes from their monthly cycle through menopause. Along the way, we get into hormone replacement therapy, why so many women blame themselves before they ever think to blame their hormones, and the bigger pattern underneath it all: how much of diabetes research and care has historically centered men, and what it costs women when it does. There's also a genuinely great story about how Melissa met her husband, who also lives with type 1 — on the side of the road, of all places. This one's for anyone managing type 1 diabetes as a woman, anyone who loves someone who is, or anyone who's ever felt like their body changed the rules without telling them why. Chapters: 00:00 Cold open and introducing Melissa Slemp 01:21 Welcome, and 44 years living with type 1 diabetes 02:24 Diagnosed in 1982, before glucometers existed 04:03 Reframing: the best and hardest time to have diabetes 04:59 Growing up rural with limited access to healthcare 07:09 Early management: injections, mixed insulin, urine strips 07:46 A high-risk pregnancy in the 90s 08:13 Switching to a pump after 40+ years on injections 10:24 How Melissa met her husband, also living with T1D 13:06 Introducing the hormone and diabetes connection 20:14 Rising basal needs and insulin resistance in perimenopause 25:25 Community stories and menopause's hidden career toll 29:44 The gender gap in diabetes research 33:04 Hormones, GLP-1s, and insulin as hormone therapy 36:03 Advocating for yourself with doctors and specialists Resources: Melissa's Book: Highs, Lows, & Hormones: A Survival Guide for Women With Diabetes From Monthly Cycles to Menopause The Menopause Society Type 1 In Midlife Podcast

Summer doesn't have to be a season you recover from. Episode #265

As over-the-counter continuous glucose monitors (CGMs) become more common, clinician guidance matters more than ever. In this episode of BackTable Women's Health, Dr. Nicole Faulkner welcomes Dr. Nicholas Canelo, a family medicine physician and founder of the Perlman Wellness CGM program, to discuss how to effectively guide CGM use in OBGYN practice, from preconception and PCOS to pregnancy and perimenopause. They highlight the importance of interpreting data trends, setting realistic glucose targets, and supporting patients through the practical and emotional challenges of CGM use. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction04:58 - CGMs in Women's Health07:33 - OTC Data Sharing Issues09:52 - Pregnancy Glucose Targets16:20 - Accuracy and Variability20:10 - Anxiety and Eating Disorders24:41 - Counseling and Follow-Up28:29 - Prescription and OTC CGM Picks37:24 - False Lows and Sensor Errors41:23 - Alarm Settings and Logging44:06 - Interpreting Metrics and Limits46:44 - Provider Dashboards 48:42 - Final Thoughts --- More about this episode Given the lack of well-established blood glucose targets outside of type 1 diabetes, Dr. Canelo reviews commonly used ranges for individuals without diabetes, those with prediabetes, and pregnant patients with type 1 or 2 diabetes. He explains how to interpret CGM data, including the time in tight range, coefficient of variation, and the importance of focusing on overall trends rather than isolated glucose spikes. They also discuss the potential drawbacks associated with CGM use, including anxiety and eating-disorder risks. Practical considerations include sensor inaccuracies, false lows readings, and optimizing alarm settings. Dr. Canelo emphasizes the importance of having patients log meals and other events while wearing the sensor and scheduling follow-up after the initial 15-day wear period to ensure accurate interpretation and effective counseling. Finally, they compare OTC and prescription CGM options, including costs, clinician access to patient data, and insertion tips. --- Resources Stelo - Over the Counter CGM Optionhttps://www.stelo.com/en-us --- BackTable Women's Health is the go-to podcast for gynecologists, gynecologic surgeons, and other healthcare professionals focused on women's health. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Diabetes technology is evolving faster than most people realize — and Ken and Graham break down exactly what that means for your day-to-day management. Plus, Ken closes with something every person living with diabetes needs to hear right now.

What if I told you that there's a diabetes organization that will write a check to help a family pay for the supplies they need right now. Diabetes Will Way helps families afford insulin pumps, CGMs, and other diabetes technology when insurance falls short. I'm talking to Will Oberndorfer, the company's namesake, as he takes over running the non profit from his mother and godmother, who founded it more than a decade ago. We talk about the growing number of young adults struggling to pay for care, why some families are considering going without insurance altogether, and the surprising trends his organization is seeing from the front lines of diabetes affordability. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our previous episode with Lisa Oberndorfer click here Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

In this episode, we sit down with Dr. Sarah Pederson, a holistic OBGYN and founder of Vera Health and Fertility, to explore a refreshing and deeply restorative approach to women's health and fertility. After years in traditional obstetrics and gynecology, Dr. Pederson recognized a gap in care, one that often prioritizes symptom management over true healing. That realization led her to build a practice centered on identifying and addressing root causes, helping women restore hormone balance and optimize fertility naturally. Together, we dive into the foundational role of nutrition, the power of continuous glucose monitoring, and the often-overlooked connection between gut health and reproductive function. This conversation challenges conventional fertility approaches and offers a hopeful, science-backed path forward for women seeking to understand their bodies more deeply. Dr. Pederson's journey from conventional OBGYN to holistic care Why a root-cause approach is essential for hormone balance and fertility The “Six Pillars” of hormone health: diet, sleep, exercise, stress, weight, and mindset/spirituality How nutrition, especially protein intake and breakfast timing, impacts hormones The hidden effects of sugar and artificial sweeteners on inflammation and fertility How Continuous Glucose Monitors (CGMs) provide personalized insights into metabolic health The connection between gut health and reproductive function A look into Restorative Reproductive Medicine and how it differs from conventional fertility treatments Key Takeaways 1. Fertility starts with foundational health Dr. Pederson emphasizes that true hormone balance begins with lifestyle: what we eat, how we sleep, how we manage stress, and how we care for our bodies as a whole. 2. Food is powerful data Using tools like CGMs allows women to see in real-time how their body responds to certain foods empowering personalized, effective changes. 3. Gut health matters more than you think Underlying gut dysfunction and inflammation can significantly impact fertility, and addressing these issues can lead to profound outcomes. 4. Healing over bypassing Unlike conventional approaches that may override the body's natural processes, restorative reproductive medicine works to heal and support the body—leading to healthier pregnancies and long-term outcomes. Interested in being a Podcast Sponsor with THE HORMONE GENIUS? Check out these links next to get more detailson our SPONSORSHIP VISION! PODCAST PARTNER: docs.google.com/forms/d/e/1FAIpQL…Q0iRgHqg/viewform MONTHLY SPONSOR: docs.google.com/forms/d/e/1FAIpQL…al5nkGyA/viewform BRAND PARTNER: docs.google.com/forms/d/e/1FAIpQL…d8-G5qaA/viewform Sponsors

Biohacking and longevity are everywhere—CGMs, peptides, cold plunges, sauna protocols, and expensive testing—all chasing the same outcome: live longer and function better.But here's what most people miss: the strongest longevity principles aren't new. They're ancient. They're biblical. And modern science keeps “discovering” what God already designed. In this episode of The OWN IT Show, Justin breaks down 5 biblical habits for longevity—and the science behind why they work—through one core lens: health is worship, not performance.You'll learn:✅ Sabbath (Recovery): why your body needs a real stop—and why God called it holy ✅ Fasting (Cellular repair): what autophagy is, and why fasting is formation—not a flex ✅ Community (Belonging): why covenant community builds resilience (and why “networking” isn't the same)✅ Movement (Strength + stamina): why discipline is stewardship for the long haul ✅ Food (Whole ingredients): why “grandma food” still wins—simple, recognizable, minimally processedThe deeper point: longevity without purpose becomes “optimization without telos”—better numbers, but an unchanged life.If this hit you, share it with someone chasing health—but missing the why. And remember: we were given the right answers for free… so take care of the temple. ============================================================================Our Sponsor:The Rise of the Health Haven Documentary — Watch the full story of how Justin and Alyse transformed their backyard into a purpose-built wellness sanctuary. From the vision to the build to the partners who made it possible, The Rise of the Health Haven is a front-row look at what a life designed around health, faith, and intention actually looks like in practice: https://bit.ly/4v6lYE8RTA Outdoor Living: RTA Outdoor Living helps families create safe, personalized outdoor kitchens built to last. Through expert guidance, premium American-made materials, and a simplified one-stop process, we help homeowners transform their backyards into meaningful spaces for connection, cooking, and lasting memories. https://rtaoutdoorliving.com/Support the show

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham tackle one of the most fascinating and controversial questions in the diabetes world:What will happen first—a cure for Type 1 diabetes or a way to prevent it altogether?The conversation begins with a discussion around continuous glucose monitors, the barriers to bringing new diabetes technology to market, and why FDA approval plays such a significant role in innovation and accessibility.From there, Ken and Graham zoom out to examine diabetes on a global scale. They explore the challenges people with diabetes face in developing countries, the realities of insulin access, and whether advanced technology like CGMs should be prioritized when many people still struggle to obtain life-saving insulin.The discussion then shifts into the future of Type 1 diabetes research, including Teplizumab (Tzield), immunotherapy, stem cell research, autoimmune triggers, and the ongoing debate between prevention and cure.Along the way, Ken shares his perspective on the role that lifestyle factors—including stress, sleep, nutrition, exercise, and overall health—may play in autoimmune conditions, while Graham challenges the conversation by exploring whether vaccines, immunotherapy, or preventative treatments could eventually become the standard approach.This episode is an honest discussion about innovation, skepticism, hope, and the future of diabetes care.

Can Direct Primary Care really pay off for a physician family carrying student loan debt and no employer match? In this episode of the My DPC Story podcast, host Dr. Maryal Concepcion talks with Dr. Manuel Vogt of Texas DPC about the real financial tools behind building a thriving practice.From a billboard at a railroad crossing to a 220-patient pre-enrollment list on opening day, Dr. Vogt shares how he and his wife built two separate Direct Primary Care clinics in San Antonio while protecting each other's autonomy. The standout story: how they used federal and state historic preservation tax credits, ADA credits, and a solar carport credit to fund a clinic renovation, then sold the state credits for 93 cents on the dollar.In this episode you'll learn:How a physician couple runs two independent DPC practices as a familyUsing historic tax credits to fund a clinic renovationSubleasing clinic space to cover your entire overheadMarketing to employers through a multi-clinic DPC umbrellaA workaround for Texas dispensing laws and discounted wholesale labsBetter diabetes care with CGMs and same-day textingFinding the panel size (around 500) that supports a daily 5K and school pickupsA pricing strategy that raises rates without losing patientsAdvocacy priorities: in-office dispensing and FSA eligibilityWhether you are a resident exploring Direct Primary Care or an established DPC owner planning expansion, this conversation is full of practical, money-saving ideas.

In this episode, Meg Bomley shares her T1D journey from being diagnosed at 18 years old and spending eight years on MDI without a CGM, to becoming someone who feels deeply empowered in her body and her diabetes.Meg first came on the podcast in 2022 after graduating from Risely coaching. At the time, she had just come out of a season of constant lows, burnout, and feeling completely overwhelmed after switching to a pump without the support she needed.Today, she's back as a nationally board certified health coach, and 35 weeks pregnant with type 1 diabetes, one of Risely's top coaches.The majority of this conversation is the reality of navigating pregnancy with T1D: the nausea, insulin resistance, fear of highs, changing carb ratios, and learning to trust yourself in this season.WHAT WE COVER:Why Meg resisted pumps and CGMs for nearly 8 years after diagnosisThe “biggest disaster ever” that happened when she first switched to a pumpWhat finally helped her stop feeling resistant, overwhelmed, and burnt out with diabetesHow coaching helped her uncover mindset blocks that had nothing to do with insulin or carb countingThe first sign Meg noticed that told her her insulin resistance was changing after getting pregnantHow she managed nausea, vomiting, insulin on board, and eating mostly carbs during pregnancyThe difference between taking 5 units for oatmeal pre-pregnancy vs. 16 units during pregnancyWhat it's actually like mentally to watch yourself take “large amounts of insulin” every dayWHAT'S NEXT:

What diabetes technology is actually helping people right now—and how do you figure out what fits best into your life?In this 100th episode of the TCOYD Podcast, Dr. E and Dr. P are joined by diabetes nurse practitioner and educator Rachael Sood, founder of The Diabetes Collective, to talk through the latest updates in diabetes technology and what they're seeing in real-world diabetes care.The conversation focuses on how much diabetes technology has changed over the past few years, from hybrid closed loop systems and CGMs to new developments in sensing and automation. Rather than focusing on one “best” device, the discussion centers around finding the right fit for each person's lifestyle, preferences, and goals.Dr. E, Dr. P, and Rachael also talk about where technology may be headed next, including dual glucose and ketone sensors, more compatibility between pumps and CGMs, and the possibility of systems that require less hands-on work from people living with diabetes. The takeaway is encouraging: there are more tools and options than ever before, and diabetes technology continues to move toward making daily management simpler, safer, and more flexible.Key Topics• Choosing the right insulin pump and CGM• Tubed vs. tubeless pump systems• How lifestyle and personal preference shape technology choices• The latest updates in automated insulin delivery systems• Dexcom G7 10-day vs. 15-day sensors• Abbott's dual glucose and ketone sensor technology• Medtronic's newest technology developments• Real-world conversations patients have about wearing devices• Continuous ketone monitoring and DKA prevention• The future of fully closed loop systems• Why compatibility between pumps and CGMs matters• Technology options for people with type 2 diabetes• Where diabetes technology may be headed next✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Ken and Graham dive into one of the most overlooked parts of living with diabetes: the stories, beliefs, and identity patterns we create over time.What starts as a conversation about childhood experiences, sports, discipline, and self-worth evolves into a much deeper discussion about how people approach diabetes management—and why so many struggle with consistency, burnout, and decision-making.Ken opens up about growing up without a strong male role model, feeling like he had to figure everything out alone, and how those experiences shaped the way he approached school, sports, and eventually diabetes. The conversation connects these personal experiences directly back to Type 1 diabetes and the reality that most people naturally gravitate toward what feels easiest, most enjoyable, or least mentally exhausting.Ken and Graham also unpack:why people avoid pre-bolusing even when they know it helpsthe frustration with pumps and CGMs not being “perfect”how people pick and choose where they spend mental energyand why diabetes management has to fit into real life—not replace itThe episode finishes with a powerful hypothetical conversation:What if Ken had been diagnosed with diabetes in high school instead of adulthood?That leads into a raw and honest discussion around denial, immaturity, identity, athletics, mental health, and how different life experiences shape the way people respond to diabetes.This episode is deeply personal, reflective, and relatable for anyone who has ever struggled to balance diabetes with actually wanting to live life.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Ken and Graham dive into one of the biggest frustrations people living with Type 1 diabetes face: the gap between medical care and real-life diabetes management.The conversation starts with a powerful discussion around endocrinologists, insulin safety, and why most healthcare providers are forced to prioritize preventing dangerous lows over helping patients aggressively optimize blood sugars. Ken explains how fear of hypoglycemia, liability, and limitations within the healthcare system shape the guidance many people receive.From there, the episode evolves into a deep real-world conversation around:insulin pumps and automationdawn phenomenoninsulin resistance from stresslearning patterns and building “checklists”trusting Dexcom trend arrowsand how to actually troubleshoot blood sugar problems in real timeGraham also shares a brutally honest look into the mental frustration of waking up high from dawn phenomenon despite doing “everything right,” leading to a conversation many people with diabetes quietly relate to but rarely talk about openly.This episode blends education, emotional reality, and practical problem-solving into one of the most relatable diabetes conversations yet.

It's In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: XX Dexcom announces some features of it's next generation CGM – the G8. We've been talking about this with CEO Jake Leach for a while now – it will be a 50% smaller with what they're calling advanced sensing capabilities. According to Leach, G8 will adapt to the physiologic variability of each user. It has additional technology built in, based on a new silicon chip design and algorithm. 15 day wear is now the baseline for all Dexcom sensors moving forward. At launch the G8 will only measure glucose but the plan is for a multi-analyte version to follow. That would measure ketones and potassium. Ketones we know – but potassium is very important for people with kidney and possible for people taking some diabetes meds. It's an interesting space to watch.. btw, analyte is just a medical word for the specific thing you're measuring – the target of the test you're running. we're going to hear that word a lot I think..   Looks like an FDA submission for the G8 next year.. with an outside the US launch the following year. https://www.drugdeliverybusiness.com/dexcom-unveils-next-gen-g8-cgm/ XX Glucotrack has submitted its implantable continuous blood glucose monitor (CBGM) for FDA IDE, that's investigational device exemption and would enable the company to initiate a U.S. clinical study for the fully implantable technology. Rutherford, New Jersey-based Glucotrack's device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. The implant goes five centimeters within the subclavian vein. Glucotrack's active implantable device has a small battery and some electronics that go just under the skin in the pectoral region. The location of the implant is not in a major vessel, but the implant can measure real-time glucose levels as pulsatile blood flows over the tip of the sensor. https://www.drugdeliverybusiness.com/glucotrack-submits-long-term-implantable-cbgm-fda-ide/ XX PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. However, this system would be one device that features both the pump and CGM technology.   PharmaSens and SiBionics also have a collaboration aimed at developing the all-in-one solution. They are jointly developing the next-generation Niia insulin patch pump with a SiBionics CGM. PharmaSens expects a second feasibility study in the second quarter to evaluate the next-generation pump with SiBionics' CGM.   PharmaSens says the clinical feasibility study of Niia demonstrated for the first time ever that the combined offering is, in fact, feasible. It believes its device addresses the need for alternatives to multi-device diabetes management. systems.   Aggregated MARD for the investigational device came in at 11.6%. A MARD target of less than 10% is considered ideal for CGM devices, but PharmaSens said that, in the context of the early feasibility study, the results were encouraging and provide evidence supporting the development of an all-in-one system. https://www.drugdeliverybusiness.com/pharmasens-efs-insulin-patch-pump-cgm/ XX   XX ViCentra launches the newest version of the Kaleido pump system in Europe. This is that small colorful pump, with Diabeloops algorithm and the Dexcom G7. It'll be in Germany and the Netherlands later this summer. https://hellokaleido.com/vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system/--   XX Diabeloop just got CE Mark approval for DBLG2 integrations – it's latest AID platform the company has kicked off the gradual European launch of the technology. It currently offers DBLG2 as a smartphone application on Android, with iOS integration coming soon. As you just heard, it's integrated with kaleido and the company says it plans to make additional configuration for DBLG2 with alternative pumps "available soon." Running on a user's smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery. https://www.drugdeliverybusiness.com/diabeloop-fda-next-gen-algorithm-g7/   XX Among adults with type 1 diabetes (T1D), the initiation of GLP-1-based therapy was associated with a lower risk for all-cause death, several cardiovascular outcomes, all-cause hospitalisations, and hypoglycaemia, without a higher risk for diabetic ketoacidosis.   METHODOLOGY: Researchers in Greece conducted a retrospective cohort study utilising real-world data from a global health research network to evaluate the association between GLP-1-based therapy and cardiovascular and renal outcomes in adults with T1D. A total of 4088 patients receiving GLP-1-based therapies (median age, 43 years; 34.3% men) were propensity score matched with an equal number of patients not receiving the treatment. The risk for hypoglycaemia was lower with GLP-1-based therapy (hazard ratio, 0.72; P = .021); however, the risk for diabetic ketoacidosis did not differ significantly between the two groups. https://www.medscape.com/viewarticle/glp-1-drugs-tied-cardiovascular-benefits-t1d-2026a1000fbx   XX Eli Lilly and Company (NYSE: LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy. The findings from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN, were presented at the 33rd European Congress on Obesity (ECO) and published in The Lancet and Nature Medicine, respectively.   "Weight regain remains one of the biggest challenges in obesity care, and is often the result of treatment interruptions that cause biology to work against patients, undoing the progress they've made," said Louis J. Aronne, M.D., FACP, DABOM, founder and Chair Emeritus of the American Board of Obesity Medicine, former president of The Obesity Society, Fellow of the American College of Physicians, world-renowned obesity specialist and Lilly consultant. "These medicines can be used for long-term maintenance today, and results from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN provide additional evidence of their potential when switching from higher doses of injectable incretin therapy." https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-and-lower-dose-zepbound-helped-people-maintain XX Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. Long way to go, as we say with most of these mice studies. https://www.sciencedaily.com/releases/2026/05/260505234620.htm XX Interesting look at how the body controls sugar storage – apparently this finding challenges long-standing biology concepts and could open new directions for disease treatment. Published in Nature, the study describes a potential method for directly reducing glycogen, the stored form of sugar in the body. These scientists discovered that glycogen can be directly regulated by ubiquitin, a protein best known for marking damaged proteins for recycling or removal. The study is the first to show that ubiquitin can regulate glycogen in humans, overturning more than 50 years of scientific understanding. Excess glycogen is also associated with more common health problems, including diabetes, obesity, liver disease, and heart disease.       https://scitechdaily.com/scientists-just-rewrote-biology-hidden-mechanism-could-transform-diabetes-treatment/ XX A new Oklahoma law will give parents the option to have their children screened for Type 1 Diabetes.   The measure passed with overwhelming bipartisan support in the Legislature and takes effect Nov 1. Oklahoma consistently ranks among the states with the highest rates of diabetes and diabetes-related deaths. The law gives parents access to antibody testing that can detect risk years before symptoms develop, helping families take preventive action and avoid emergency room visits. https://journalrecord.com/2026/05/11/oklahoma-law-expands-access-type-1-diabetes-screening/ XX More to come including a new study trying to figure out why some people are more likely to develop diabetes, a look at cannabis and preventing metabolic disorders, and XX   A National Institutes of Health (NIH)-funded study has identified key differences in human pancreatic islet cells that may help explain why some people are more likely to develop diabetes. Researchers found that the mix of hormone-producing cells in the pancreas varies widely from person to person, and that variation plays a central role in how the body regulates blood sugar. The study involved a deep dive into islet cell function that is linked to donor traits associated with observable characteristics, or phenotype, such as sex, race and ethnicity, as well as genetic information, or genotype, including predicted ancestry and genetic risk for both type 1 and type 2 diabetes. The findings highlight that islet cell composition, rather than the physical size and shape of islets, is a key factor in regulating hormone release. The team found that the makeup of pancreatic islets plays a major role in how effectively they release insulin and glucagon — key hormones that regulate blood glucose. Islets with a higher proportion of insulin-producing beta cells showed stronger insulin secretion in response to various stimuli, while higher levels of alpha and delta cells were generally linked to reduced insulin output. In addition, the researchers found that islet hormone secretion is affected by donor traits, such as sex, race and ethnicity and their genetic makeup, including ancestry predicted from genetic testing and genetic risk for type 2 diabetes. Combined, the findings of the study have significant implications for understanding the factors that may predispose people to diabetes. "This study is the tip of the iceberg," said Dr. Evans-Molina. "We hope this dataset becomes useful to the entire diabetes research community and that researchers use it to answer questions about the genotype-phenotype correlation within these data."   https://www.nih.gov/news-events/news-releases/nih-funded-study-maps-human-pancreatic-islet-cells-offering-new-clues-diabetes-risk XX XX XX Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.   "This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer – whether this is related to weight control, improve cardiovascular health or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Ph.D., MPH, associate director for population sciences and the Gordon D. Ginder, M.D., Chair in Cancer Research at VCU Massey Comprehensive Cancer Center.   Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.   What are GLP-1 drugs? Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Approved to treat type 2 diabetes in 2005 and weight management in 2021. Impacts on breast cancer survival and recurrence are still unclear. Since 2020, the use of these drugs has increased dramatically, where approximately 12% of Americans have used GLP-1s for weight loss, according to a RAND report.   The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes.   GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients. Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.   "Our findings align with emerging preclinical research and contribute to a growing body of literature related to GLP-1 RA use in oncology settings," said study lead author Kristina L. Tatum, PsyD, MS, of the VCU School of Public Health.   What's next? Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes. The research team intends to further evaluate these correlations through randomized clinical trials.   "Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making," Fuemmeler said. https://www.oncology-central.com/could-glp-1-receptor-agonists-improve-outcomes-for-breast-cancer-patients-with-obesity-or-with-type-2-diabetes/ XX Researchers at UC Riverside gave cannabis to obese mice and found that not only did the rodents lose weight, but when given a concentrated cannabis oil, the mice also saw striking benefits in their metabolic function. DiPatrizio said his team studied the issue to better understand why cannabis users show significant reductions in weight and risk for diabetes compared with nonusers. "We would think that chronic cannabis users would be eating more and weigh more, but it's just the opposite," DiPatrizio said. Scientists are increasingly examining the possibility that cannabis compounds could fight obesity or metabolic disorders like diabetes. Cannabinoids interact with the body's endocannabinoid system, which partially controls nearly every aspect of our physiology, including metabolism and appetite. That creates the possibility that targeting this widespread system could unlock new therapies for these conditions. https://www.sfgate.com/cannabis/article/cannabis-weight-loss-california-study-22255328.php XX A new campaign launched by diaTribe and Genentech aims to empower and educate people about diabetes-related eye disease. Here's what you can do today to protect your eye health. To help address these barriers, diaTribe and Genentech partnered to launch All Eyes on DME, a new campaign that aims to spread awareness and educate people at-risk for or living with diabetes-related eye conditions like DME. Also partnering in the campaign is actor and comedian Damon Wayans, who wanted to share his journey (and, of course, a joke or two) with type 2 diabetes to open up the conversation about what is often a stigmatized or less talked about topic: eye health and diabetes.   One of these important conversations happened recently at the All Eyes on DME launch in New York City, where Wayans joined a panel of experts, advocates, and people living with DME to talk about diabetes-related eye disease and how to help prevent it. https://www.alleyesondme.com/dme-in-the-spotlight.html https://diatribe.org/diabetes-complications/all-eyes-dme-new-campaign-spotlights-eye-health-and-diabetes

Rafael Pepen was diagnosed with Type 1 diabetes at 17, right in the middle of rehearsing for his very first musical in the Dominican Republic. Without access to a CGM or carb counting education, he learned to manage largely on instinct. Years later, he moved to the US, pursued his dream of performing professionally, and eventually landed at Disney, where he now performs five high cardio shows a day.In this episode, Rafael sits down with Lauren to talk about what it actually looks like to manage T1D in a life that never slows down. He shares the months of burnout, panic attacks around lows, and constant roller coaster blood sugars that led him to seek coaching, and what shifted on the other side of that.WHAT WE COVER:What it was like to be diagnosed at 17 in the Dominican Republic with limited access to education, CGMs, or carb counting guidanceThe unique challenge of managing T1D across five high cardio shows a day and why it is a completely different beast from a traditional performance scheduleThe moment things started to unravel at Disney and what five months of daily lows, panic attacks, and burnout actually felt like from the insideWhat shifted when Rafael started working with a Risely coach and the tools that made the biggest difference for his day to day managementThe emotional side of T1D that most people never talk about, including what it felt like to cry during a low and the moment that started to changeWhat Rafael is still working toward and the one thing he wants most from his relationship with diabetes going forwardWHAT'S NEXT:

Cortisol is getting blamed for basically everything online, and we get why it's tempting: it gives a neat explanation for feeling tired, stressed, bloated, or “off.” But as a family medicine doctor and a nurse, we want to bring the conversation back to what cortisol actually does, what real testing looks like, and why most people don't need to treat normal life stress like a hormonal crisis.From there, we zoom out to other trendy health topics we keep seeing everywhere: gut health and the microbiome, pricey supplement stacks, and the promise that one test will finally explain your symptoms. We talk about the evidence and the limits, plus the unglamorous basics that move the needle for most people: fiber, plants, sleep, exercise, and cutting back on ultra-processed foods.We also dig into CGMs and “glucose spikes,” including what's normal (yes, exercise can raise glucose) and what actually signals risk, like blood sugar staying elevated after meals. Then we hit high-protein culture, why protein helps, why more isn't always better, and how longevity trends can distract from what matters most. Our bottom line: wellness marketing moves faster than science, so we aim for practical, evidence-based choices you can stick with.If you found this helpful, subscribe, share it with a friend who's stuck in health-trend overwhelm, and leave a review so more people can find the show.Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.Support the showProduction and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RNArtwork Rebrand and Avatars:Vantage Design Works (Vanessa Jones) Website: https://www.vantagedesignworks.com/Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qrOriginal Artwork Concept: Olivia Pawlowski

Fasting, nutrient timing, chrono-nutrition, and continuous glucose monitoring are all topics that have generated substantial interest, but they are also areas where exaggerated claims can easily outpace the underlying evidence. In many cases, tentative hypotheses are presented as if they were already well-established conclusions, despite the fact that the research base is often more mixed and context-dependent than popular narratives imply. It is one thing for an idea to appear biologically coherent. It is another for that idea to translate into meaningful, reliable effects in real-world interventions. In this episode, Professor James Betts discusses how to think clearly about these topics, why common errors in interpretation can lead to overstated conclusions, and what is required to properly evaluate whether an observed effect reflects a true intervention effect rather than baseline differences, inappropriate comparisons, within-group changes, or mechanistic signals being mistaken for meaningful health outcomes. Timestamps: [04:24] Background into Prof. Betts' research [07:28] Evidence in fasting research over past 5-6 years [10:15] Hype vs evidence in intermittent fasting [16:44] Spotting spin in study conclusions [17:31] Common statistical red flags [24:45] Methods matter in fasting trials [31:10] Exercise nutrient timing [38:32] CGMs what they measure, misuse and patterns [53:59] Key ideas (premium-only)   Links: Go to episode page & resources (study links, bio, etc.) Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

What if your genes are not your destiny, but a set of clues your body has been giving you all along? In this episode, Dr. Taz sits down with Dr. Florence Comite, endocrinologist, clinician scientist, longevity expert, and author of Invincible: Defy Your Genetic Destiny to Live Better, Longer, to explore how biomarkers, genetics, hormones, sleep, metabolism, and family history shape the way we age.In this episode, Dr. Comite explains why longevity is not just about biohacking, supplements, peptides, or the latest wellness trend. Instead, she shares why true healthspan begins with understanding your own body, your own patterns, and your own family story. She explains how changes in blood sugar, fasting insulin, free testosterone, cholesterol risk ratio, sleep quality, muscle, and metabolism can reveal early signs of disease risk long before symptoms fully appear.Dr. Taz and Dr. Comite discuss why “normal” lab ranges are not always the same as optimal health, why some people begin showing signs of metabolic disease decades earlier than expected, and how family history can act as a powerful roadmap for prevention. They also explore how genetics, lifestyle, hormones, wearables, continuous glucose monitoring, sleep, movement, protein, and personalized medicine may help people change the trajectory of their future health.If you're listening to this and thinking, “I know something is off in my body, but I don't know where to start,” join the Circle here:

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham open up a conversation that doesn't get talked about enough—intimacy and relationships while living with diabetes.From managing BS during intimate moments to navigating confidence, communication, and vulnerability, this episode highlights a side of diabetes that often gets overlooked.Ken and Graham break down the real-life challenges people face, including concerns about highs and lows, wearing devices like CGMs or pumps, and the mental load that can show up in relationships.The conversation expands into how diabetes can impact self-image, confidence, and connection, and why avoiding these conversations can create more stress over time.

We can measure more about our health than ever before. Wearables track everything from heart rhythms to glucose trends, and AI can now identify patterns clinicians might miss. But more data does not automatically mean better health outcomes.In this episode, cardiologist and digital health expert Dr. Ami Bhatt joins Mike Haney to explore why medicine still struggles with prevention, how continuous health data can help patients take more agency, and where AI may actually improve care—not by replacing doctors, but by helping clinicians navigate the right information at the right time.They discuss the promise and pitfalls of wearables, the challenge of turning constant streams of health information into useful action, and why the future of medicine may depend on what Dr. Bhatt calls “collaborative intelligence”: humans and AI working together to make better decisions earlier.About the guest: Dr. Ami Bhatt is the chief innovation officer (CIO) at the American College of Cardiology and the Chair of the FDA Digital Health Advisory Committee. She received her undergraduate degree at Harvard University and her Doctor of Medicine at Yale University School of Medicine, and was the Director of Outpatient Cardiology, TeleCardiology, and Adult Congenital Heart Disease at the Massachusetts General Hospital.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠⁠⁠

This week on The AGEIST Podcast, Dr. Florence Comite,  clinician-scientist, and author of Invincible: Defy Your Genetic Destiny to Live Better, Longer, explains why “normal” lab results can miss the early signals that shape long-term health. Learn how sugar, insulin, A1C, cholesterol patterns, HDL, and free testosterone can reveal metabolic changes before a conventional diagnosis appears. She makes the case for tools like CGMs, deeper family history, better sleep, strength training, and hormone awareness as practical ways to understand what is happening beneath the surface. The episode gives the audience a clear framework for asking better questions, acting earlier, and taking more precise ownership of the next decades of their health.Are you competing in the Super Age Games? Join us at the first longevity fitness competition on Nov 7, 2026. Visit games.superage.com to learn more.Special Thanks to Our SponsorsTimeline Nutrition: Our favorite supplement for cell support and mitochondrial function. Listeners can now get 20% off their first Timeline purchase by using the code “AGEIST” at checkout at TimelineNutrition.com/ageist.LMNT Electrolytes: Our #1 electrolyte brand for optimal hydration, and their new 12oz sparkling cans are officially for sale online! Get a free Sample Pack of LMNT's most popular drink mix flavors with any purchase by using our link here. Find your favorite LMNT flavor, or share with a friend.Key Moments“I want everyone to own their future health destiny.”“The first phrase that's completely wrong is you're in the normal range and everybody relaxes.”“Aging is not a disease, it's a gift.”Connect with Dr. ComiteWebsiteComiteMDInvincible: Defy Your Genetic Destiny to Live Better, LongerConnect with AGEISTNewsletterInstagramWebsiteLinkedInClick Here for the full interview transcript.Say hi to the AGEIST team!

Most high performers don't realize they're running at 70% until someone shows them what 100% feels like. Dr. Tracy Gapin did —, and it changed everything. He was a busy urological surgeon: overweight, stressed, and ironically receiving the same inadequate "normal" care he was giving his own patients. So he walked away from traditional medicine to build something better.In this episode of The Daily Mastermind, George Wright III sits down with Dr. Tracy Gapin — founder of Peak Launch and author of Male 2.0 — to break down why high performers are the most likely to ignore the symptoms quietly destroying their decisions, their leadership, and their longevity. And more importantly, exactly how to fix it.This isn't a conversation about being "healthy." It's about optimizing the biological systems that determine how you lead, decide, and perform under pressure.What You'll Learn:– Why high performers normalize feeling "off" — and why that gradual decline is so dangerous– The most common blind spots: low testosterone, cortisol dysfunction, and microbiome imbalance– Why traditional medicine's volume-based model keeps missing what high performers actually need– Dr. Gapin's "Test, Design, Track" system — advanced biomarkers, personalized plans, and wearables– What peptides actually are, how they work, and why sourcing matters more than most people know– How CGMs (continuous glucose monitors) reveal what no standard lab test can– Why sleep quality — not just duration — may be the single highest-leverage optimization available– How to treat proactive health as a core leadership and business strategy01:07 Why He Left Urology03:06 High Performers Focus04:31 Feeling Off Explained07:01 Blind Spots: Hormones & Gut08:42 Stress and Entrepreneur Myths11:03 Why Doctors Are Behind the Science13:29 The Test, Design, Track System16:41 Key Biomarkers to Test18:20 Peptides: Safety Basics21:45 Tracking Outcomes and the App24:08 Wearables, CGMs & Sleep27:23 Cortisol and Night Wakeups29:10 Health as a Business Strategy30:24 The Future: AI and Individualized MedicineThanks for listening, and Please Share this Episode with someone. It would really help us to grow our show and share these valuable tips and strategies with others. Have a great day.George Wright III“It's Never Too Late to Start Living the Life You Were Meant to Live”FREE Daily Mastermind Resources:CONNECT with George & Access Tons of ResourcesGet access to Proven Strategies and Time-Test Principles for Success. Plus, download and access tons of FREE resources and online events by joining our Exclusive Community of Entrepreneurs, Business Owners, and High Achievers like YOU.Join FREE at DailyMastermind.comFollow me on social media Facebook | Instagram | Linkedin | TikTok | YoutubeGrow Your Authority and Personal Brand with a FREE Interview in a Top Global Magazine HERE.About the Guest:Dr. Tracy Gapin is a renowned physician, TEDx speaker, and the founder of Peak Launch, a precision performance medicine practice dedicated to helping high-achieving men and women optimize their health. With over 25 years of medical experience and as the author of Male 2.0, he specializes in using epigenetics and advanced diagnostics to restore energy and focus. Guest Resource:Website: https://drtracygapin.com/Instagram: https://www.instagram.com/drtracygapin/Facebook: https://www.facebook.com/drtracygapin/LinkedIn: https://www.linkedin.com/in/tracygapin/

Have you ever found yourself down a late night rabbit hole, adding something to your cart that promised to fix everything? It's never been easier to reach for the supplement, the protocol, the skincare your favorite influencer is praising. We're living in the most exciting time in wellness history. Peptide stacks, CGMs, red light therapy, cold plunges, biohacking tools… and a $6.8 trillion industry that keeps growing. Some of these innovations can genuinely improve our health and our lives. But somewhere in the middle of all this innovation and optimization, we started skipping steps. And I think we've lost the plot. No supplement stack can out-supplement poor sleep. No peptide replaces a meal made from real food. No gadget rewires a nervous system that's running on chronic stress and negative self-talk. You cannot build anything lasting on a shaky foundation. You need the fundamentals, the basics that will actually move the needle. In this episode, you'll learn: How your inner narrative directly impacts digestion and nutrient absorption The unglamorous habit that outperforms most cleanses, detoxes, and supplements Why one simple morning habit can improve your sleep A fun way to nourish every cell in your body The mindset shift that makes movement feel natural, not forced The two "essential nutrients" that can elevate your quality of life When the foundations are solid, everything else works better. Including all the latest wellness biohacks and innovations.   Resources Mentioned: Shift Your Inner Narrative Stress Less While Eating  More on 30 plants a week study Advanced Sleep Tips Walk Your Way to Clarity and Calm  EWG website: www.ewg.org Elise's favorite water bottle recommendation (non-plastic)   Learn More about Elise Museles: Rise & Shine Coaching Program (50% discount for podcast listeners) Food Story: Rewrite the Way You Eat, Think, and Live Website: elisemuseles.com Instagram: @elisemuseles Facebook: @elisemuseles

Social Media Is Confusing Your Patients. In this episode, I'm joined by endocrinology PA Emily Stevens to discuss diabetes, insulin resistance, and blood sugar control and help you explain it in a way your patients will actually understand. If your patients are asking about glucose spikes, CGMs, keto, or supplements like berberine, this episode will give you clear, practical answers you can use in clinic this week.What You'll Learn: Why "glucose spikes" are normal and how to explain this to patients without causing fear  The truth about low-carb, keto, and intermittent fasting for diabetes management  Why telling patients to “cut carbs” or “avoid fruit” is wrong advice How to use the Diabetes Plate Method for quick, effective nutrition counseling  Why pairing protein + carbohydrates improves glycemic control (and how to teach it fast)  What the evidence says about berberine, magnesium, and supplements When lifestyle changes are enough vs when medication is necessary Who actually benefits from continuous glucose monitors (CGMs) (and who doesn't) Key Takeaways for the Exam Room:Blood sugar isn't meant to be flat. Help patients expect “rolling hills,” not a straight line. Carbs aren't the problem. Focus on quality, pairing, and portions. Start with beverages. It's often the fastest win for improving glycemic control. Don't demonize fruit. You'll create fear instead of sustainable change. Meet patients where they are. “Cut it in half” works better than “cut it out.” You can't out-supplement a poor diet. Food first, always. Use visuals, not numbers. The plate method > gram counting for most patients.Connect with EmilyAny Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week.Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer. 

Host Eric Malzone sits down with Marco Benitez, CEO and Co-founder of ROOK — and former TaeKwondo champion turned biomedical engineer — to get real about where the fitness and wellness industry stands in the age of AI and wearable data. Marco pulls from his background at Roche and Novartis to explain why clean, unified data is the foundation everything else is built on, and why most operators are sitting on gold they don't know how to mine. From pharma clinical trials using Oura rings to track narcolepsy patients, to longevity brands leveraging sleep data to drive upsells, to the looming reality of AI agents reshaping how we interact with health professionals — this conversation doesn't sugarcoat anything. Eric and Marco also dig into the "dead internet" theory, AI hallucinations, self-driving cars, and why soft skills might be the most valuable thing you can develop right now. If you're in fitness, healthcare, or anywhere near the wellness space and you're not thinking seriously about your data strategy, this episode is your wake-up call. Key Takeaways:

Metabolic health is often simplified to a matter of blood sugar, but at its root, it is a complex system of energy substrate signaling. While many view chronic disease as an inevitable part of aging, a systems-thinking approach reveals that maintaining high "flux"—the capacity to efficiently move and clear energy through the body—is the primary lever for longevity. Without the stimulus of regular movement, even the most optimized diet can fail to prevent the accumulation of metabolic waste that leads to insulin resistance and heart disease.In this episode, we sit down with Greg Mushen, a technologist who turned his engineering mind toward his own biology after conventional medicine failed to address his chronic health issues. Mushen breaks down his "Theory of Flux" and why he believes the key to disease resistance lies in meeting our body's "clearance burden". From studying the activity levels of hunter-gatherer populations to debunking myths about walking and V2 max, Mushen provides a data-driven framework for optimizing health through the lens of evolutionary biology and systems engineering.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠⁠In this episode, we cover:The Theory of Flux: Understanding health as the dynamic capacity to move nutrients and fuel through the system rather than a static set of markers.Insulin Resistance Reimagined: Why blood sugar is a symptom, not the root cause, and how fat accumulation in the liver and muscle disrupts signaling.The Power of PAL: Why a Physical Activity Level (PAL) of 2.0 is the "golden ratio" observed in disease-free subsistence populations.Walking vs. HIT: De-bunking the idea that you need high intensity to improve V2 max and why the "area under the curve" for oxygen consumption is what matters.The Saturated Fat Paradox: Comparing the Messiah and Chimané populations to understand how high activity levels can mitigate the risks of high-fat diets.Fiber as a Sensor: Why fiber is more than just "throughput" and acts as a critical environmental sensor for metabolic signaling.The "Walking Grifter" Philosophy: Why walking is the most under-leveraged tool for increasing metabolic flux with the lowest recovery cost.

Plus size fashion news, brands I refuse to give my money to, and ranting about a new Serena Williams commercial promoting a CGM as a "wellness hack." 

A $50 sensor on your arm, real-time data on your phone. The question isn't whether CGMs work. It's whether they're right for you. In this episode, Jeff takes a clear-eyed look at continuous glucose monitors. After wearing one revealed his own pre-diabetes, he spent years sorting the signal from the noise. Here's what CGMs show, what they miss, and who should actually use one. Inside the episode: How CGMs work, and why the 8 to 10% error margin matters Why your CGM is secretly one of the most honest stress monitors you can wear The glucose numbers worth knowing (and the ones to ignore) Why insulin resistance can precede a glucose spike by years The four CGM archetypes: Optimizer, Controller, Outsourcer, Curious Tourist The four biomarkers to check before you strap one on This episode is for anyone thinking about metabolic health, pre-diabetes, insulin resistance, or whether a continuous glucose monitor belongs on their arm. This episode was made possible by: Bon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNE LMNT: Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinklmnt.com/commune. Vivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 15% off your order at vivobarefoot.com/commune. Beyond Biohacking: Save $400 on any ticket with code COMMUNE400 at beyondconference.com. Sunlighten:  Visit sunlighten.com/commune  Up to 2,100 off saunas and $50 off Red Light Products with code “COMMUNE”

If midlife wellness feels overwhelming, you're not imagining it.Everyone has an opinion. Every scroll brings a new protocol. Eat this. Don't eat that. Lift heavier. Do less. Fix your hormones. Try this supplement.And most women? They're trying to do all of it—and still not feeling better.In this episode of Asking for a Friend, Michele sits down with Raquel Cartagena and Kristin Brucker, hosts of the Functional Moms Podcast, to cut through the noise and have an honest conversation about what it really takes to feel good in midlife.This is not a surface-level conversation. It's real, nuanced, and at times uncomfortable—because the truth is, there is no one-size-fits-all solution.We cover: Why midlife health feels so confusing and overwhelming  The biggest missing piece for women over 40 (and it's not another diet)  Functional medicine vs. traditional health approaches  The reality behind GLP-1s—benefits, concerns, and real-world experiences  Blood sugar, CGMs, and why “healthy foods” don't always work for your body  Fiber, protein, and the habits that actually move the needle  Alcohol in midlife—and the trade-offs most women ignore  Hormone replacement therapy (HRT): what to consider and why it's not one-size-fits-all  Supplements: what actually matters vs. what's just noise  Longevity strategies to stay strong, capable, and independent This episode is about taking your power back—learning to filter the noise, understand your body, and build a lifestyle that actually works for you.Functional Moms - https://functionalmoms.com/https://www.instagram.com/functionalmomspodcast/Save 25 percent off every supplement order courtesy of the Functional Moms:Functional Moms Fullscript StoreMichelle Doel and Alicia HardingMetabolism Mastery Class with CGMhttps://www.instagram.com/metabolism_mastery_coaches/https://metabolism-mastery.com/_________________________________________If you're doing “all the right things” and still feel stuck, adding a layer of support may be an option. I've partnered with a trusted telehealth platform offering modern solutions for women in midlife—including micro-dosed GLP-1 and other peptide therapies.https://elliemd.com/michelefolan - Create a free account to view all products.Follow us on Instagram https://www.instagram.com/askingforafriend_pod/✨ Sign up for my weekly newsletter: https://michelefolanfasterway.myflodesk.com/i6i44jw4fqLike to connect? Email me at askingforafriendpodcast1@gmail.com Transcripts are created with AI and may not be perfectly accurate.Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your qualified healthcare provider with any questions regarding a medical condition.

Mike Collins has been completely sugar-free for over 35 years. He is the founder of SugarDetox.com and SugarAddiction.com, past chairman of the board of the Food Addiction Institute, and the creator of the Quit Sugar Summit. He has helped over 60,000 people break their sugar dependency and has spent a decade interviewing more than 400 of the world's leading experts on sugar, addiction, and metabolic health. He and his wife raised two children without sugar until the age of six, and both of his sons scored perfect on their college entrance exams.This is one of the most eye-opening episodes we've done on this show. Sugar isn't a willpower problem. It's a brain chemistry problem, and Mike explains exactly why, and what to do about it.In this episode, we cover:Why sugar addiction is the largest substance use disorder the world has ever known — and why it's not your faultHow sugar affects dopamine, serotonin, GABA, oxytocin, endorphins, and every brain reward chemical — not just oneThe connection between sugar, drugs, and alcohol — and why so many people in recovery can't put sugar downWhy sugar stunts emotional development starting in childhood — and how it compounds over a lifetimeHow Mike's mother's story explains why so many of us learned to equate sugar with love, comfort, and rewardSugar as the "good girl's drug" — why women ages 50–80 make up 95% of his clients and what that says about people-pleasing and emotional soothingWhy "eat less, exercise more" is a $78 billion lie that doesn't address the actual problemThe difference between conditioned guilt, emotional eating, and true sugar addictionWhat dopamine dysregulation actually means — and whether those receptors can come backHis 90-day approach to behavioral change and why he calls it a recovery program, not a dietGLP-1s, Ozempic, and why the most interesting research will be about what they're doing to the brain — not the bodyWhy over-supplementing may be stalling your weight loss — and what the liver has to do with itContinuous glucose monitors (CGMs), how to use one, and his free book CGMs for Everybody on AmazonAlzheimer's, brain clarity, and why he believes sugar is a neurotoxinThe journaling practice he recommends — tracking how you felt before and after eating, not just what you ateWhat to say to yourself when a craving hits — and the simple self-check that changes everythingConnect with MikeWebsite: https://sugardetox.com Instagram: https://www.instagram.com/realsugarfreeman/YouTube: https://www.youtube.com/@SugarAddictionPlease remember to rate, review, and follow the show – and share with a friend!Subscribe to the newsletter:https://mailchi.mp/amyedwards/sign-up-to-amys-newsletterCheck out our new Comedy Wellness Podcast: Anything But Mid, cohosted with Whitney Stropp:https://podcasts.apple.com/us/podcast/anything-but-mid/id1849386215https://www.youtube.com/@AnythingButMidFind Amy's affiliates and discount codes: https://amyedwards.info/affiliatepageAll links: ⁠⁠⁠amyedwards.info⁠⁠⁠Instagram: ⁠⁠⁠@realamyedwards⁠⁠⁠Fight For Her: ⁠⁠⁠fightforher.net⁠⁠⁠TikTok:⁠⁠⁠ @themagicbabe⁠⁠⁠YouTube: ⁠⁠⁠YouTube Channel⁠⁠⁠Podcast: ⁠⁠⁠The Amy Edwards Show Podcast⁠⁠⁠Free Course:⁠⁠⁠ The Ageless Mindset⁠⁠⁠Full Course: ⁠⁠⁠The Youthfulness Hack⁠⁠⁠Amy's hair by ⁠https://www.thecollectiveatx.com⁠Podcast editing by https://podcastmagician.com/Get my FREE course "The Ageless Mindset: The Ultimate Guide to Look Younger and Feel Happier!" HERE: ⁠https://best-you-life.teachable.com/p/the-ageless-mindset-the-ultimate-guide-to-look-younger-feel-happier⁠Get the full course “The Youthfulness Hack: The Secret System to Reverse Aging Fast and Create a New, Radiant You!” Out now! ⁠https://best-you-life.teachable.com/p/the-youthfulness-hack⁠

In this episode I sat down with metabolic researcher Andrew Koutnik to break down the science of metabolic health, insulin resistance, and ketogenic diets. We explore why most people struggle with energy crashes, cravings, and weight loss resistance, and how blood sugar regulation plays a central role in long term health. Andrew shares insights from decades of research and personal experience living with type 1 diabetes, including how the body adapts to carbohydrate reduction, what metabolic flexibility actually means, and why keto is often misunderstood.→ Leave Us A Voice Message!  Topics Discussed: → What is metabolic flexibility and why does it matter? → How long does it take to adapt to a ketogenic diet? → Does keto improve insulin resistance and energy levels? → Why do people feel tired when starting low carb diets? → What is the best way to balance blood sugar naturally? Sponsored By:  → LMNT | Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at https://drinklmnt.com/Kelly. Find your favorite LMNT flavor, or share with a friend. → Be Well By Kelly Protein Powder & Essentials | Get $10 off your order with PODCAST10 at https://bewellbykelly.com. Timestamps:  → 00:00:00 - Introduction → 00:01:37 - Diabetes + Nutrition  → 00:06:41 - Obesity + Insulin → 00:10:32 - Glucose Spikes  → 00:14:51- CGMs  → 00:15:28 - Blood Sugar Red Flags  → 00:19:30 - Reducing Carb Intake → 00:28:52 - Defining Metabolic Health → 00:34:00 - Meal Timing → 00:38:22 - Intermittent Fasting → 00:41:20 - Ketosis + Metabolic Flexibility  → 00:46:50 - Nutrition Experimentation → 00:50:59 - Nutrition Fundamentals → 00:55:50 - Food Swaps  → 01:01:51 - Performance Changes  → 01:06:27 - Sodium + Children's Snack  → 01:13:24 - Children's Sugar Intake  → 01:16:25 - Children's Nutrition  Further Listening:  → Why You're Always Hungry + How to Fix It | Dr. Jason Fung Check Out Andrew: → Website  → Instagram  → YouTube Check Out Kelly: → Instagram → Youtube → Facebook

Protein is often hailed as the ultimate nutrient for health and longevity, but the science suggests it is only half of the equation. While social media influencers debate the minutiae of protein grams, researchers have found that the vast majority of protein's benefits are "baked in" only when combined with physical activity. Without the stimulus of exercise, even the most optimized protein intake fails to move the needle on muscle growth or chronic disease prevention.In this episode of A Whole New Level, Mike Haney sits down with Dr. Stuart Phillips, a researcher who has spent over 25 years at McMaster University studying the intersection of protein, exercise, and human health. Dr. Phillips breaks down why the current RDA for protein is likely too low for optimal health and why the methodology used to set those standards is decades out of date.Dr. Phillips explains the "brick wall" analogy of muscle turnover—where synthesis and breakdown are in a constant tug-of-war—and how lifting weights acts as the primary driver for "the bricklayers". From the impact of anabolic resistance in aging to the truth about protein timing and kidney health, he provides a grounded, data-driven perspective on how to maintain a functional reserve of muscle as we age.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠In this episode, we coverThe RDA Debate: Why the standard 0.8 g/kg recommendation is a "preventing deficiency" baseline rather than an "optimized health" target.The Power of Exercise: Why 80% to 90% of protein's benefits are dependent on physical activity.Muscle as a Storage Depot: Understanding muscle as a functional reserve that dictates disease resistance and survival.Anabolic Resistance: How inactivity and aging make our cells less efficient at using amino acids.The Myth of Timing: Why the "anabolic window" is more like a "garage door" that stays open much longer than once thought.Protein Quality & Source: Comparing animal vs. plant proteins and why the "food matrix" matters more than isolated powders.Kidney Health: De-bunking the 60-year-old hypothesis that high protein intake causes kidney damage in healthy individuals.

In this episode of The Body GrieversⓇ Club, Bri interviews dietitian and certified diabetes educator Kristie Messerli (The Type 2 Diabetes Nutritionist) about type 2 diabetes, insulin resistance, medication, and the shame and fear that often follow diagnosis. Kristie explains diabetes in lay terms, emphasizing insulin resistance as the underlying issue, genetics as a major driver, and the nuance beyond "cut carbs, lose weight, exercise more," especially for women already dieting and exercising. They discuss complications as largely tied to unmanaged diabetes, the reality that medication may still be needed as the pancreas becomes less efficient, and myths about reversal, prediabetes, and weight loss. Kristie also breaks down GLP-1s, cautions against CGMs for people without diabetes/prediabetes, and shares resources, including her Balanced Blood Sugar Method and provider training group. 03:19 Diabetes Explained Simply 06:14 Is Type 2 Your Fault? 12:54 Common Fears and Complications 17:56 Myth or Fact? 21:55 Hormones, Thyroid, and PCOS 29:36 Genetics Loads the Gun 31:45 Healing Trust With Food 43:03 GLP1s Explained 49:20 Medication Fear and Risks 55:58 Diabetes Shame and Culture 59:08 Resources and Next Steps   WANT MORE OF KRISTIE? Connect with Kristie on Instagram https://www.instagram.com/type2diabetes.nutritionist/  WANT MORE OF BRI? *Instagram: @bodyimagewithbri
 *Website: https://bodyimagewithbri.com/ *Bri's Free Resource: 7-Step Guide to Shift Body Grief to Radical Body Acceptance https://www.bodyimagewithbri.com/seven-steps 

How do we help patients improve health span without letting wearables, biomarkers, and wellness trends take over the conversation? Learn how to think about CGMs in patients without diabetes, how to interpret early cardiometabolic risk beyond the A1c, how to prescribe exercise in a practical way, and how to counsel patients about sleep, wearables, and even peptides. We're joined by Dr. Sandeep Palakadedi (Dr. “Deep”), founder and CEO of Velocity Health and author of The Ultimate Asset.Claim CME for this episode at curbsiders.vcuhealth.org!Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CMEShow Segments Intro CGMs, Postprandial Glucose, and Data Neurosis Beyond Glucose: ApoB, Lp(a), and Early Cardiometabolic Risk Body Composition, VO2 Max, and Functional Longevity Sleep, HRV, and Wearables Prescribing Exercise in Real Life How to Talk to Patients About Peptides Take-Home Points CreditsWritten and produced by Paul Wurtz MD. Show notes, cover art, and infographic also created by Paul Wurtz MD. Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai S Achi MD, MBA, FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Sandeep Palakodeti MD, MPH DisclosuresDr. Palakodeti reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures. Sponsor: MINT MOBILEShop plans at MINTMOBILE.com/CURB.Sponsor: FIGSWe've teamed up with FIGS, and now Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX. Sponsor: Continuing Education CompanyFor Curbsiders listeners, there's a special offer: use promo code Curb30 for 30% off all online courses and webcasts. Visit CMEmeeting.org/curbsiders to learn more.  

Modern medicine has come a long way in its fight against diabetes. We now have continuous glucose monitors (CGM) and automated insulin delivery (AIDs) systems. These have revolutionized patient care. The FDA has approved devices for use in pregnancy as “nonadjunctive use” (meaning they may be used alone), although capillary finger stick assessments are currently still considered the Gold Standard. While the most robust data in support of CGMs is for preexisting Type 1 DM (Class B or beyond) and Type 2, there is recent growing support for CGM use in GDM patients, although some limitations still apply. Listen in for details.1. Feig DS, et al; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017 Nov 25;390(10110):2347-2359. doi: 10.1016/S0140-6736(17)32400-5. Epub 2017 Sep 15. Erratum in: Lancet. 2017 Nov 25;390(10110):2346. 2. Benhalima K, Durnwald C, Sweeting A et al.Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statementThe Lancet Diabetes & Endocrinology, 2025; 14, 157-1773. Salmen BM, Reurean-Pintilei D, Salmen T, Bohîlțea RE. Exploring Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review. Life (Basel). 2025 Aug 28;15(9):1369. doi: 10.3390/life15091369. PMID: 41010309; PMCID: PMC12470761.4. Wyckoff JA, Lapolla A, Asias-Dinh BD, et al.Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism. 20255. American Diabetes Association Professional Practice Committee for Diabetes*; 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026. Diabetes Care 1 January 2026; 49 (Supplement_1): S321–S338. https://doi.org/10.2337/dc26-S0156. Burk J, Ross GP, Hernandez TL, Colagiuri S, Sweeting A. Evidence for improved glucose metrics and perinatal outcomes with continuous glucose monitoring compared to self-monitoring in diabetes during pregnancy. Am J Obstet Gynecol. 2025 Sep;233(3):162-175. doi: 10.1016/j.ajog.2025.04.010. Epub 2025 Apr 10. PMID: 40216177.7. Linder T, et al; GRACE study collaborative group. Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial. Lancet Diabetes Endocrinol. 2026 Jan;14(1):50-61. doi: 10.1016/S2213-8587(25)00288-8. Epub 2025 Nov 24. PMID: 41308662.8. Valent AM, et al. Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial. Diabetes Care. 2025 Sep 1;48(9):1581-1588. doi: 10.2337/dc25-0115. PMID: 40730104; PMCID: PMC12368369.9. Kusinski LC, et al. Continuous Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes Mellitus: A Secondary Analysis of the DiGest Trial. Diabetes Care. 2025 Aug 19:dc250452. doi: 10.2337/dc25-0452. Epub ahead of print. PMID: 40828742; PMCID: PMC7618813.10. García-Moreno RM, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2022 Jan;39(1):e14703. doi: 10.1111/dme.14703. Epub 2021 Oct 13. PMID: 34564868.11. Amylidi-Mohr Set,.et al (DipGluMo): an open-label, single-centre, randomised, controlled trial. Lancet Diabetes Endocrinol. 2025 Jul;13(7):591-599. doi: 10.1016/S2213-8587(25)00063-4. Epub 2025 May 26. Erratum in: Lancet Diabetes Endocrinol. 2026 Mar;14(3):e6. doi: 10.1016/S2213-8587(25)00403-6. PMID: 40441173.

Yet more GLP1 news this week.  People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle.  So are a tool that biohackers have known about for years - CGMs - the answer?  Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management. Follow Sharam Fouladgar-Mercer on LinkedIn.